Application of noninvasive neuromodulation in patients with asthenic neurosis

The relevance of the work is associated with the high prevalence and socio-economic significance of neurotic disorders associated with stress. Standards of medical care for patients with neurotic disorders associated with stress do not provide for the use of any physiotherapy or hardware effects. Drug therapy is mainly used, but its use is not always effective and is limited by the risk of developing allergies, drug addiction, toxic manifestations, side effects, etc. Therefore, more and more attention has been paid to non-drug treatment methods recently. Non-invasive neuromodulation is a therapeutic exogenous effect on various parts of the nervous system using an electromagnetic physical factor in the conditions of drug therapy.

Purpose. Study the effectiveness of noninvasive neuromodulation in patients with asthenic neurosis.

Material and methods. A total of 79 patients with the diagnosis of F48.0 — Neurasthenia were studied (59 women and 20 men). The median age was 44 ± 4.5 years. The main group — 49 patients, 30 patients made up the control group. The course of non-invasive neuromodulation was performed against the background of medical treatment in accordance with the MES with the use of a pulse generator "TETOS" with feedback in the form of electroencephalography (registration certificate no.FRS2011/11198).

Results. Immediately after the end of the course of treatment, 80% of patients manage to achieve a significant improvement in their subjective state. As a result of the proposed method, not only significant, but also persistent improvement in the condition of patients is achieved.

Conclusions. The basis of this method is the interaction of two methods of treatment: physiotherapy and medication. As a result of the application of the proposed method, the main cause of the disease (psychotraumatic factor, life circumstances, etc.) is gradually identified, and the patient himself becomes aware of it, with subsequent correction of the condition. As a result, not only significant, but also persistent improvement in the condition of patients is achieved. According to the results of observations of the authors of the application, the disease does not resume for 1.5–2 years.